InvestorsHub Logo
Followers 56
Posts 6344
Boards Moderated 0
Alias Born 10/01/2012

Re: None

Thursday, 05/22/2014 2:25:20 PM

Thursday, May 22, 2014 2:25:20 PM

Post# of 38634

This shelf prospectus is intended to give Intellipharmaceutics the flexibility to take advantage of financing opportunities when, and if, market conditions are favorable to the Company.



So what I assume will happen is after shelf prospectus approval there will be some dilution by the company into a PPS run after an ANDA(s) is approved?

I think 100 million is a lot of shares now but not so many @ $10. $15 or $20 a share, I hope they think their strategy out well.